Literature DB >> 19559727

Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.

Mehdi Houimel1, Koussay Dellagi.   

Abstract

A human immune Fab library was constructed using RNAs from peripheral blood lymphocytes obtained from rabies virus hyperimmune volunteers on phagemid vector. The size of the constructed Fab library was 2 x 10(7) Escherichia coli transformants. After four rounds of panning on whole inactivated rabies virus (PV-11), phage clones displaying rabies virus-specific human Fab were selected. The specificity of soluble Fab antibody fragments, derived from positive phage clones was verified by ELISA. Among 20 specific Fab clones, the genetic sequence of 6 of them (FabRV01, FabRV02, FabRV03, FabRV04, FabRV05, and FabRV06) was analyzed. The variable heavy (VH) and variable light (VL) domains were found to share 90% and 93% homology with sequences encoded by the corresponding human germline genes, respectively. The soluble Fab fragments, expressed in Escherichia coli were purified by a single step Nickel-NTA affinity chromatography via a hexa-histidine tag and their binding specificities to rabies virus were confirmed. Three of the Fab antibodies, FabRV01, FabRV02 and FabRV03, showed binding characteristics to rabies virus glycoprotein antigenic site III with affinities in the K(D) range 7 x 10(-9) to 5 x 10(-8)M. The Fab fragments showed dose-dependent neutralization properties for the challenge virus standard (CVS-11).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559727     DOI: 10.1016/j.jviromet.2009.06.018

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus.

Authors:  Chen Li; Feng Zhang; Hong Lin; Zhong-can Wang; Xin-jian Liu; Zhen-qing Feng; Jin Zhu; Xiao-hong Guan
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

2.  A parallel panning scheme used for selection of a GluA4-specific Fab targeting the ligand-binding domain.

Authors:  Rasmus P Clausen; Andreas Ø Mohr; Erik Riise; Anders A Jensen; Avinash Gill; Dean R Madden; Jette S Kastrup; Peter D Skottrup
Journal:  Int J Biol Macromol       Date:  2016-07-08       Impact factor: 6.953

3.  Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection.

Authors:  N V Tikunova; V V Morozova
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

Review 4.  Advances in the progress of monoclonal antibodies for rabies.

Authors:  Linlin Fan; Li Zhang; Jingxin Li; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2022-02-16       Impact factor: 3.452

5.  Single domain antibody multimers confer protection against rabies infection.

Authors:  Bhargavi M Boruah; Dawei Liu; Duan Ye; Tie-Jun Gu; Chun-Lai Jiang; Mingsheng Qu; Edward Wright; Wei Wang; Wen He; Changzhen Liu; Bin Gao
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

Review 6.  Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

Authors:  Leonard Both; Ashley C Banyard; Craig van Dolleweerd; Edward Wright; Julian K-C Ma; Anthony R Fooks
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

Review 7.  Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

Authors:  Leonard Both; Ashley C Banyard; Craig van Dolleweerd; Edward Wright; Julian K-C Ma; Anthony R Fooks
Journal:  Pediatr Pol       Date:  2013-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.